| Methods |
Randomised prospective cross‐over design,
study conducted at the University of Oklahoma Health Sciences Center and Veterans Administration Medical Center |
| Participants |
12 Nondiabetic hyperkalaemic patients on stable haemodialysis regiment |
| Interventions |
a) regular insulin 10 units with glucose 50 mL of 50% solution IV over 5 minutes,
b) nebulised treatment of albuterol 20 mg in 4 mL normal saline inhaled over 10 minute period,
c) combined regimen consisting of intravenous insulin and dextrose as well as a nebulised albuterol treatment |
| Outcomes |
Plasma potassium,
Plasma glucose
Plasma insulin |
| Notes |
|
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
